The phospholipase D (PLD) gene from Corynebacterium pseudotuberculosis has been cloned, sequenced, and expressed in Escherichia coli. Analysis of DNA sequence data reveals a major open reading frame encoding a 31.4-kilodalton protein, a size consistent with that estimated for the PLD protein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Comparison of these data with the amino-terminal protein sequence indicates that the mature PLD protein is preceded by a 24-residue signal sequence. Expression of the PLD gene in E. coli is initiated from the corynebacterial promoter, and the resulting protein has sphingomyelinase activity. Primer extension mapping localized the 5' end of the PLD gene mRNA to a site 5 to 7 base pairs downstream of a region similar to the consensus sequence for E. coli promoters. Northern and Southern blot analyses suggest that the gene is transcribed from mRNA approximately 1.1 kilobases in length and that it is present in a single copy within the C. pseudotuberculosis genome.
Corynebacterium pseudotuberculosis is the gram-positive bacterium responsible for the disease in sheep known as caseous lymphadenitis or cheesy gland. The pathogenesis of caseous lymphadenitis usually involves entry of C. pseudotuberculosis through broken skin, following which the bacteria are carried to the local lymph node. Once established, they multiply to cause inflammation, necrosis, and abcessation of the node (3) . An important factor in the dissemination of C. pseudotuberculosis within an infected animal is the production of an exotoxin, phospholipase D (PLD) (2) . Sheep can be vaccinated against caseous lymphadenitis by using detoxified PLD prepared from C. pseudotuberculosis culture supernatants (2; D. G. Eggleton, J. A. Haynes, H. D. Middleton, and J. C. Cox, submitted for publication).
Studies with partially purified PLD indicate that it is a sphingomyelinase with a molecular mass of about 31 kilodaltons (kDa) and a pl of 9.2 to 9.6 (7). However, there have been no previous reports describing the purification of this toxin to homogeneity, and no amino acid sequence data are available. Here we report the cloning, expression, and complete nucleotide sequence of the C. pseudotuberculosis PLD structural gene.
MATERIALS AND METHODS
Bacterial strains and plasmids. Escherichia coli DH5ot (Bethesda Research Laboratories, Inc.) was the host for plasmids pUC12 and pUC118 (18) . The Commonwealth Serum Laboratories (CSL) production strain of C. pseudotuberculosis (West Australian Department of Agriculture, strain 1030) and an isolate from New Zealand (isolate 107) were used in this study. The plasmids pCSL33, pCSL39, and pCSL40 were constructed during this study. pCSL33 is pUC12 containing the PLD gene on a 2.7-kilobase (kb) fragment. pCSL39 and pCSL40 were derived by subcloning a 1.5-kb Sacd fragment ( Fig. 1 ) from pCSL33 into pUC118. In pCSL39 the PLD gene is transcribed in the opposite direction to the lacZ gene, whereas in pCSL40 it is transcribed in the same direction.
Media. E. coli strains were grown in Luria broth (10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl per liter) containing 30 ,ug of ampicillin per ml. C. pseudotuberculosis was grown in nutrient infusion broth (NIB; 500 ml of veal extract [CSL], 5 g of NaCl, and 10 g of proteose peptone per liter).
Toxin purification. Toxin was purified from C. pseudotuberculosis culture supernatants by cation-exchange chromatography (J. C. Cox, J. A. Haynes, D. Drane, E. Pietrzykowski, and I. Roberts, manuscript in preparation).
Assay for C. pseudotuberculosis PLD. C. pseudotuberculosis PLD activity was detected by using a modification of the Zaki assay (15, 17) and an assay to detect sphingomyelinase (4) . For the Zaki assay 1.5-ml samples of a 15% (vol/vol) suspension of sheep erythrocytes in Alsevers solution were washed three times in 5 ml of buffered saline (0.01 M N-tris(hydroxymethyl)-methyl-s-aminoethane sulfuric acid, 0.01 M MgCl2, 0.85% [wt/vol] NaCl, and 0.1% [wt/voll bovine serum albumin [pH 7.3]). The washed cells were then diluted 10-fold in buffered saline. Doubling dilutions of test samples (100 RIl) in buffered saline were made in microdilution trays. Samples (100 ,ul) of washed sheep erythrocytes were then added to each test sample and held at 37°C for 45 min. Beta-lysin (CSL special product) (50 ,u) was then added to each test well, and the trays were held at 37°C for 30 min and then on ice for 30 min. Microdilution trays were spun in a Beckman GPR bench-top centrifuge for 30 s at 400 x g. The number of Zaki units present in a given sample was determined from the dilution of PLD test sample that no longer protected the blood cells from lysis by staphylococcal beta-hemolysin. Tests were standardized against a stock solution of PLD. The sphingomyelinase assay was performed at pH 7.4 as described by Gatt et al. (5) Preparation of oligonucleotides. PLD-specific oligonucleotides deduced from N-terminal PLD protein sequence data were synthesized by using an Applied Biosystems 380B DNA synthesizer. Oligonucleotides for screening gene libraries were prepared as mixtures to accommodate codon degeneracy or incorporated inosine residues at equivocal positions (13) . Oligonucleotides to be used as sequencing primers were designed from derived DNA sequence data. Tritylated oligonucleotides were purified with oligonucleotide purification cartridges (Applied Biosystems).
Labeling oligonucleotides. Oligonucleotides were 5' end labeled (10) by using 50 ,uCi of -y-ATP (3,000 Ci per mmol; Amersham Corp.) and T4 polynucleotide kinase (5 U) to a specific activity of at least 107 dpm/,ug.
Isolation of genomic DNA from C. pseudotuberculosis. A 10-ml overnight culture of C. pseudotuberculosis was used to inoculate 200 ml of NIB containing 1.0 p.g of penicillin per ml. After growth overnight at 37°C, the culture was centrifuged (14,000 x g, 10 min), and the pellet was suspended in 10 ml of STET (8% sucrose, 0.5% Triton X-100, 50 mM EDTA [pH 8.0], 10 mM Tris hydrochloride [pH 8.0]) containing 10 mg of lysozyme per ml. The mix was held at 37°C for 2 h, and 3.0 ml of lysis solution (1.0% [wt/vol] sodium dodecyl sulfate, 0.2 M NaOH) was then added. After a further hour at 55°C the lysate was centrifuged at 47,800 x g for 30 min. Chromosomal DNA was isolated from the cleared lysates by using cesium chloride-ethidium bromide gradients (10) .
Construction and screening of genomic library. Genomic DNA (22 Rg) from C. pseudotuberculosis was partially digested with 6 U each of HaeIII and AluI. Digests were run on a 1.0% agarose gel; fragments between 2 and 4 kb were excised, purified with Geneclean (Bresatec, Adelaide), and cloned into the SmaI site of pUC12. Ligation mixes were transformed into E. coli DH5ot. Transformants were screened by using a rabbit anti-PLD serum (Cox et al., in preparation) and a SuperScreen immunoscreening system kit (Amersham). Expression of PLD gene in E. coli. Cultures (1 ml) of E. coli harboring the toxin gene were pelleted and suspended in 100 ,ul of lysis buffer (12.5 ,ug of lysozyme per ml of STET). The mix was centrifuged, and 80 ,ul of supernatant was used in each assay. Lysates were tested for the production of PLD by using Western blotting (immunoblotting) and the modified Zaki test. For the sphingomyelinase assays, periplasmic extracts were prepared by the method of Kendall et al. (9) .
Restriction mapping, subcloning, and Southern blotting. A restriction map of an antibody-reactive clone (pCSL33) was derived by using standard procedures (10) . Plasmid DNA carrying the putative PLD gene was digested with PstI or Sacl, and the fragments were Southern blotted to nitrocellulose. Filters were hybridized (12) at room temperature with a toxin-specific end-labeled probe (5'-GTIGTICAC/TAAC/ TCCIGC-3') for 2 h in 6x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-lOx Denhardt solution (10) , washed at increasing stringency as necessary (up to 45°C), and exposed to X-ray film (Fuji RX).
DNA sequence analysis. M13 clones were sequenced by using modified T7 DNA polymerase according to the instructions of the manufacturer (U.S. Biochemical Corp.) with either universal primer or synthetic oligonucleotides. Segments of overlapping DNA sequence were generated by using oligonucleotide primers designed from the PLD sequence as it became available. Sequence data were collated and analyzed by using the DNASIS software package (Pharmacia Fine Chemicals).
Primer extension. Total RNA was isolated from E. coli and C. pseudotuberculosis as described by Aiba et al. (1) . Then 0.1 to 10 pmol of oligonucleotide primer (5'-TTGAGTGGT TAAAACGCGGTGGGC-3') was end labeled (10), ethanol precipitated, and annealed to 20 ,ug of RNA. Primer extension was accomplished at 42°C for 1.5 h with 20 U of avian myeloblastosis virus reverse transcriptase (Pharmacia) under conditions specified by the manufacturer. Extension products were separated on a 6% polyacrylamide sequencing gel, which was fixed, dried, and exposed to X-ray film. Analysis of C. pseudotuberculosis RNA. Total RNA was isolated from C. pseudotuberculosis as described above. A 950-base-pair (bp) PvuII fragment containing most of the PLD gene plus a small portion of the lacZ gene was isolated from pCSL39 and labeled to a specific activity of 108 dpm/,ug with a random primer labeling kit (Bethesda Research Laboratories). RNA was electrophoresed on a 1% formaldehyde agarose gel, blotted to nitrocellulose, and then hybridized at 68°C overnight with the gene probe (10) . Size estimations were made relative to RNA molecular weight markers (Bethesda Research Laboratories).
Analysis of C. pseudotuberculosis genomic DNA. Genomic DNA isolated from C. pseudotuberculosis was restricted, electrophoresed on a 1% agarose gel, and then Southern blotted (10) to a nitrocellulose filter (Amersham). The PLD gene-specific probe was produced as described above. Hybridization was at 68°C overnight in 6x SSC. The filter was then washed in 1x SSC for 20 min at 68°C and exposed to X-ray film.
RESULTS
Cloning of the PLD structural gene. C. pseudotuberculosis genomic DNA was partially digested with AluI and HaeIII, and fragments approximately 2 kb in size were purified and cloned into the SmaI site of pUC12. A library was prepared in DH5ax, and 15,000 clones were screened by using an anti-PLD antiserum. One positive clone was identified.
A 5.6-kb plasmid (pCSL33) was isolated from this clone and mapped by using a variety of restriction endonucleases (Fig. 1) . To confirm that the 2.7-kb insert in pCSL33 contained at least part of the PLD gene, the restricted plasmid DNA was Southern blotted to nitrocellulose and hybridized with a PLD-specific oligonucleotide probe. A 1.5-kb Sacl fragment and a 200-bp PstI fragment hybridized with this probe (data not shown). Since the hybridizing oligonucleotide was designed from protein sequence data derived from the PLD amino terminus, the 5' end of the PLD structural gene must be located on the 200-bp PstI fragment (Fig. 1) gene size of around 850 bp, it is likely that the entire structural gene is contained within the 1.5-kb Sacl fragment (Fig. 1) .
Expression of the PLD gene in E. coli. The 1.5-kb Sacl fragment was subcloned into pUC118, and recombinants were identified by using the PLD-specific antiserum. Restriction analysis of a number of the clones that reacted with the antiserum revealed that the Sacl fragment was present in both orientations. This result suggests that the PLD promoter is functional in E. coli. Two plasmids (pCSL39 and pCSL40) having the 1.5-kb fragment cloned in opposite orientations were chosen for further analysis.
Cell lysates were prepared from strains harboring pCSL33, pCSL39, or pCSL40 and electrophoresed on a 12% sodium dodecyl sulfate-polyacrylamide gel. Proteins were transferred to nitrocellulose by electroblotting and then tested for reactivity with the anti-PLD antiserum. Strains containing either the original clone (pCSL33) or one of the subclones (pCSL39 or pCSL40) produced a 31-kDa protein that reacted with PLD-specific antibodies (Fig. 2) . This size is consistent with that of the mature PLD protein, indicating that the complete PLD structural gene is present on the 1.5-kb Sacl fragment.
To determine the subcellular localization of PLD produced in E. coli, lysates of strains containing pCSL39 were separated into cytoplasmic and periplasmic fractions as described previously (9) . Proteins from these fractions were separated on 12% sodium dodecyl sulfate-polyacrylamide gels and analyzed by silver staining or Western blotting (data not shown). These experiments demonstrated that PLD is predominately located in the periplasm, indicating that the PLD signal sequence functions in E. coli.
Activity of PLD produced in E. coli. PLD produced by C. pseudotuberculosis is commonly assayed by using the Zaki test, which measures the ability of PLD to block the lysis of sheep erythrocytes by staphylococcal beta-hemolysin (15, 17) . Cell lysates from all PLD clones had demonstrable activity in this assay, whereas host cells harboring plasmids without insert DNA produced no detectable reaction (data not shown).
Previous studies have shown that PLD is a sphingomyelinase (5) . In an assay that measures the hydrolysis of a synthetic substrate, trinitrophenylaminolauryl sphingomyelin, purified PLD showed reactivity similar to that of sphingomyelinase prepared from Staphylococcus aureus (Fig.3 ) . Periplasmic extracts prepared from E. coli harboring the PLD gene were also capable of hydrolyzing trinitrophenylaminolauryl sphingomyelin, whereas no activity was de- tected from extracts of E. coli cells lacking the PLD gene. These data show that a functional protein is produced when the PLD gene is expressed in E. coli.
DNA sequence analysis. The 1.5-kb Sacd fragment was subcloned in both orientations into M13mpl8. Nucleotide sequence data from both strands were derived for approximately 1,100 bp of the Sacd fragment (Fig. 4) by using a modified dideoxy-chain termination procedure (16) .
Analysis of the DNA sequence reveals a major open reading frame beginning just before the PvuII site and terminating at the end of the cloned fragment (Fig. 1) . This open reading frame is capable of coding for a 307-residue protein with a predicted size of 34.1 kDa. To confirm that this protein corresponds to PLD, the predicted polypeptide sequence was compared with the amino-terminal sequence data obtained from purified PLD. A stretch of 23 residues identical to the PLD protein sequence was identified 25 amino acids downstream from the predicted translational initiation site. The preceding 24-amino-acid sequence is strongly indicative of a signal sequence (19) . On this basis the open reading frame encodes a polypeptide that includes a putative signal peptide (2.7 kDa) and the mature PLD protein (31.4 kDa). The size of mature PLD predicted from the sequence is therefore in close agreement with that estimated by SDS-polyacrylamide gel electrophoresis (Fig.  2) .
The DNA and protein sequences of PLD were used to search the appropriate DNA (GENBANK, EMBL) or protein (NBRF) data bases for homologous sequences. Surveys of the nucleotide data bases failed to detect sequences showing significant similarity to PLD. Comparison of the PLD protein sequence with those of other phospholipases, however, revealed a small region of homology with the phospholipases A2 (Fig. 5) .
Determination of the transcriptional start site. Expression studies in E. coli indicated that the E. coli RNA polymerase can use a C. pseudotuberculosis sequence as a promoter. Inspection of the DNA sequence upstream of the PLD structural gene revealed several regions that resemble the consensus E. coli promoter. CTG TCA GCT TCT GAA ATA TAT GAG TAT AA CAT ATG CM TAA CCC TTG ATT TTA TTG TTA TTT MG TTT CAT MT GGG GAT ATA GCG CAG GGT   97   GTT CAC GCT GGT AM GGG CTA TTT TTG GGC ACC TCT CCG TGG GAA ATG TAT CCG CAA ATT ATA GTG CGA CAT CCT TTT GTT GCT CTA TTT ATC GMA   - Primer extension experiments were conducted to determine the location of the PLD promoter. A labeled oligonucleotide designed to anneal to the 5' end of the PLD mRNA was hybridized to total RNA prepared from either C. pseudotuberculosis or E. coli carrying pCSL39 and then extended by using reverse transcriptase. products were separated on a 6% sequencing gel and compared with a DNA sequence ladder generated by using the same oligonucleotide as a primer (Fig. 6) . These experiments suggested that the RNA polymerase in both E. coli and C. pseudotuberculosis initiates transcription at the thymine located at position 84 in the sequence. Based on the E. coli promoter consensus sequence (14) , two overlapping -10 regions and a -35 box were identified upstream of this putative initiation site (Fig. 4) .
Determination of PLD gene copy number in C. pseudotuberculosis. Separate samples of C. pseudotuberculosis genomic DNA were digested with restriction enzymes, electrophoresed on a 1% agarose gel, transferred to nitrocellulose, and hybridized to the same probe used for the RNA analysis (see above). With the exception of PstI, the enzymes used in this experiment were chosen because they do not have recognition sites within the PLD-coding sequence. There- fore, if the PLD gene is present more than once in the C. pseudotuberculosis genome, under stringent conditions it is likely that one or more of these enzymes will give rise to multiple hybridizing bands. Analysis of the PLD restriction map (Fig. 1 ) predicts that the probe should hybridize to 93-and 200-bp PstI-generated fragments as well as to a fragment larger than 600 bp (depending on the position of the next site downstream from the coding sequence). Since fragments of less than 300 bp were not retained on the gel, only one fragment would be detected if there were a single PLD gene. Single hybridizing bands were observed in all the tracks (Fig.  7A) , suggesting that the PLD gene is present as a single copy in the C. pseudotuberculosis genome.
Analysis of C. pseudotuberculosis RNA. Because the PLDcoding sequence finishes within 10 bp of the end of the cloned DNA, the fragment does not contain sequences resembling either transcriptional terminators for the PLD gene or the translational initiation signals for a downstream gene. To determine the size of the authentic PLD transcript, total RNA was prepared from C. pseudotuberculosis, separated on a 1% agarose denaturing gel, transferred to nitrocellulose, and hybridized to a PLD-specific probe labeled by random priming. The size (approximately 1100 bp) of the mRNA species that hybridized to the probe was similar to the size of the PLD gene (Fig. 7B ). This suggests that the PLD transcript terminates just downstream of the coding sequence. The first, beginning at base 142 (Fig. 4) , is capable of encoding a polypeptide consisting of 18 amino acids. However, there is no evidence to suggest that this polypeptide is synthesized. The predicted translational start site for the second open reading frame is a methionine codon at position -24 (Fig. 4) , which is preceded by a region similar to the E. coli consensus sequence for a ribosome-binding site (14) and also by two stop codons (Fig. 4) . The major ORF encodes a 24-residue signal sequence (19) and a 259-amino-acid (31.4-kDa) polypeptide. This structure is consistent with previous data (7) identifying PLD as a 31.0-kDa protein secreted by C. pseudotuberculosis.
Comparison of the PLD protein sequence with other phospholipases reveals some similarity to the phospholipase A2 class (Fig. 5) . It is interesting to note that this region is highly conserved among the phospholipase A2 enzymes and that both the calcium-binding and the active sites fall within it (20) . Since PLD is a magnesium-dependent enzyme, we postulate that the homologous region in PLD may contain the PLD metal-binding site.
The sequence data show that the cloned fragment does not contain transcriptional terminators. It is therefore possible that other open reading frames exist on the same transcript downstream from the PLD gene. Analysis of C. pseudotuberculosis RNA indicates that this is probably not the case, since the mRNA is approximately the same size as the gene (Fig. 7B ).
There are a number of regions upstream of the beginning of the PLD-coding sequence that resemble the consensus sequence for an E. coli promoter (14) . To determine which one is the PLD promoter, the position of the transcriptional start site was determined. Primer extension data suggest that transcription of the PLD gene in both C. pseudotuberculosis and E. coli is initiated at thymine number 84 (Fig. 4 and 6 ). Initiation at a thymine does not follow the E. coli consensus model, which favors purines (11) . However, this result may reflect the sensitivity of the primer extension technique.
Regions similar to the consensus sequences for the E. coli promoter -10 and -35 boxes are located close to this putative transcriptional start site (Fig. 4) . As observed for the Corynebacterium diphtheriae toxin gene, the PLD promoter has two possible -10 regions (6, 8) . In C. diphtheriae it has been suggested that the TAGGAT box showing optimal spacing (18 bp from the -35 region) would be used in preference to the possible alternative -10 region (TATAAT). Although the latter box is identical to the E. coli consensus sequence, it is only 12 bp from the -35 region. Recently both -10 regions were shown to function in E. coli; however, as predicted the optimally spaced -10 region was favored (4). In the case of the PLD gene, the spacing between the putative -10 (CATAAT) and -35 regions is 18 bp, thus fitting the E. coli consensus model. The other putative -10 region for the PLD gene (TTITCAT) does not closely resemble the E. coli consensus -10 box (TATAAT) and is suboptimally spaced. The question of which -10 region directs gene expression in E. coli and corynebacteria is currently being addressed.
